Table of Contents Table of Contents
Previous Page  263 / 363 Next Page
Information
Show Menu
Previous Page 263 / 363 Next Page
Page Background

1426 

C

rowley

et al

.

:

J

ournal of

AOAC I

nternational

V

ol

. 95, N

o

. 5, 2012

and TSAB cultures were 95, 96, and 97%, respectively. The

VITEK 2 GP reagents were stable over 18-month time studies

and provided highly reproducible results when compared

between lots. Assay ruggedness was demonstrated for three

critical parameters, including age of culture, inoculum density

,and inoculum age. Overall results indicate that the VITEK 2 GP

method is an acceptable automated method for the identification

of selected Gram-positive organisms. The method was awarded

PTM certification No. 120702 on December 10, 2007.

The collaborative study evaluated the ability of the

VITEK 2 GP identification method to correctly identify

720 inclusivity strains representative of 12 different claimed

organisms. A total of 120 exclusivity strains representative of

six different nonclaimed organisms were also evaluated. All

isolates analyzed were obtained from the three recommended

subculture culture media: TSA, CBA, and TSAB (6).

Collaborative Study

Study Design

A total of 20 laboratories participated in the collaborative

study, consisting of industry, government, and private testing

laboratories involved in the testing of food products. Qualified

laboratories currently using the VITEK 2 system were invited

to act as collaborators. Each participating laboratory received

18 isolates on Brain Heart Infusion (BHI) agar slants. The

identity of each isolate had been previously confirmed by

traditional biochemical confirmations and/or Certificate of

Analysis. There were 12 claimed isolates (target inclusivity

organisms; Table 1) and six isolates of exclusivity organisms

(nontarget organisms; Table 2).

A detailed collaborative study packet outlining all necessary

information related to the study, including isolate preparation

and documentation of results, was sent to each collaborating

laboratory prior to the initiation of the study. All participating

laboratories were provided with GP cards, prepared culture

media plates, and any additional supplies needed to identify

the isolates. Participants were asked to provide their own

Gram stain reagents due to challenges associated with federal

regulations in the transportation of the reagents.

Preparation of Isolates

Pure isolates of each organism from the bioMérieux (BMX)

culture collection were sent on BHI agar slants to each of the

participating laboratories. Each isolate used had been well

characterized. Microscopic and plate morphology, standard

biochemicals, at least two phenotypic methods, and, when

needed, molecular sequencing were performed. To prepare

for distribution to the collaborators, growth from each strain

was transferred to BHI agar slants from growth that had been

subcultured onto CBA and incubated for 18–24 h at 35–37°C.

Following incubation, slants were labeled and prepared for

shipment.

Isolate Distribution

All isolates were labeled with a randomized, blind-coded

3-digit number affixed to the sample vial. Isolates were

shipped in leak-proof, insulated containers on a Monday via

overnight delivery according to the Category B Dangerous

Goods shipment regulations set forth by the International Air

Transportation Association. Upon receipt on Tuesday, isolates

were streaked onto CBA to check for purity. Collaborators were

instructed to hold the original BHI agar slants in the refrigerator

at 2–5°C for the duration of the study. All isolates were shipped

at ambient temperature. Collaborators received all 18 isolates

during the same week of testing. Participants were instructed to

inspect the isolates upon receipt of the package and document

that they were received in good condition on the Sample Receipt

Confirmation form provided in the shipment. Forms were then

faxed or emailed to the study director.

Analysis of Isolates

Upon receipt of the shipment, collaborators were instructed

to streak each isolate received onto CBA to check for purity

and incubate for 18–24 h at 35–37°C. Following incubation, a

Gram stain was conducted on one isolated colony from each

strain according to the U.S. Food and Drug Administration’s

Bacteriological Analytical Manual

(FDA/BAM) method (7)

and results were recorded. Those isolates that were identified

as characteristic Gram-positive organisms were streaked to the

three recommended culture media, TSA, CBA, and TSAB, and

Table 1. Inclusivity (claimed) isolates used in VITEK 2 GP

collaborative study

Organisms

ID No.

Source

a

Origin

Listeria grayi

125274 BMX Industry

Listeria innocua

12524

BMX

Fish

Listeria ivanovii

ssp.

Ivanovii

12913

BMX Reference lab

Listeria ivanovii

ssp

. Londoniensis

12914

BMX Clinical

Listeria monocytogenes

12502

BMX Shellfish

Listeria seeligeri

6217

BMX Creamer

Listeria welshimeri

12517

BMX

Beef

Staphylococcus hyicus

13889

BMX Reference lab

Staphylococcus intermedius

16409

BMX Veterinary

Staphylococcus aureus

8819

BMX Reference lab

Staphylococcus aureus

8852

BMX Reference lab

Staphylococcus epidermidis

8890

BMX Reference lab

a

 BMX = bioMérieux culture collection.

Table 2. Exclusivity isolates used in VITEK 2 GP

collaborative study

Organisms

ID No.

Source

a

Origin

Bacillus coagulans

202608

BMX Tomato paste

Citrobacter freundii

110125

BMX Hospital

Escherichia coli

112380

BMX Beef hide

Serratia marcescens

111663

BMX Reference lab

Aspergillus niger

304232

BMX Clinical

Candida albicans

305527

BMX Reference lab

a

 BMX = bioMérieux culture collection.

Candidates for 2016 Method of the Year

262